The National Agency for Food and Drug Administration and Control (NAFDAC), says chloroquine prevents the spread of the Coronavirus.

 Director General, NAFDAC Prof. Christiana Mojisola Adeyeye, made this known during an online interactive session with journalists. 

She said findings show that chloroquine can be used in the early stage of the COVID-19 infection as prophylactic treatment. Science does not lie.”

Adeyeye said,  “On March 20, 2020 during a press briefing, I said I was going through a literature and I found out that chloroquine and remdesivir killed COVID-19 in vitro – that is in the laboratory.

In early March, there was a publication where 100 patients were treated with chloroquine in 10 hospitals across Chinese cities. I made a statement that chloroquine is only for clinical trial treatment. There has to be a level of confidence that depends on the number of subjects and results.”

 We are now understanding that it is not one drug that can be effective for COVID-19. It depends on the phase of the disease. We started working with Lagos State on clinical trial for chloroquine. We are getting to know that it is working.”

Adeyeye said : “The Director General of Senegal’s drug regulatory body that is also Director General of the regional regulatory body ordered chloroquine from a company in Ota, Ogun State, and distributed to 15 member countries. She noted that the wide usage of chloroquine is another pointer to its efficacy ”


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s